Regal Funds founder Phil King’s short share tips

An experienced investor with a track record of short selling, King will be the only fund manager on the day tipping a short stock at the annual Australian Sohn Conference on Friday.‍

Glenda Korporaal

Regal Funds founder Phil King’s short share tips

December 3, 2021
An experienced investor with a track record of short selling, King will be the only fund manager on the day tipping a short stock at the annual Australian Sohn Conference on Friday.‍
Read Transcript

Shorting shares has become increasingly difficult in the current long bull market, according to Regal Funds Management founder Phil King.

An experienced investor with a track record of short selling, King will be the only fund manager on the day tipping a short stock at the annual Australian Sohn Conference on Friday.

In the first Sohn Conference in 2016 he was one of three shorts pitching their ideas.

“It’s terribly tough to short shares in this bull market,” he said in an interview with the Australian ahead of the conference.

“This bull market is a much bigger bull market than many of the bull markets that we have seen. Many people who have tried to short have blown up.”

King cites the example of US video game company GameStop earlier this year.

When hedge funds decided to short the stock, retail investors, many of whom were roused to action by their presence on social media news aggregation platform Reddit, banded together and won.

But King still thinks short selling has a role in the current market.

“I’ve been shorting for 20 years. It’s more challenging now than it has been for a while, but there’s no doubt there’s going to be some great opportunities ahead.”

King will be tipping a well known Australian company for his short on Friday.

He believes that its shares are overvalued and it is in an industry which is changing, no longer as profitable as it once was.

“It’s been incredible over many years, but things have changed and now is the time to go short,” says King, who is careful not to reveal the stock itself.

“We’ve seen a lot of stocks bounce very aggressively from their lows last year.

“In some situations, they have bounced back too far. This is one of them.”

“It’s shares are overvalued. The world is changing and the future is going to be different to the past.”

In his last appearance at the Sohn conference, in 2019, King tipped ASX-listed health care equipment company PolyNovo as his short.

The company, which makes treatments for burns victims, defied his predictions, becoming a market darling in 2020 with its shares soaring to a high of $4 last December.

But investors have turned on the company this year and the company also saw the resignation of its chief executive Paul Brennan last month, with its shares crashing back to just over $1.40.

King founded Regal Funds Management in 2004 with his brother Andrew.

The two started investing for themselves but were soon approached by others to invest on their behalf.

The firm now has offices in Sydney and Singapore managing some $3bn, with a speciality in small and medium size companies.

While Andrew is retired, King says he is still enjoying himself running the business, riding the latest bull market.

“There’s been some tremendous opportunities out there. Some of the stocks are up 10 times on what we put in. It has been incredible.”

“There have been some themes which have worked well for us, like electrification.

“We have made a lot of money investing in electric vehicle stocks like (lithium miner) Pilbara (Minerals). We first bought its stock at around 35 cents and now it is trading above $2.50.”

Regal also bought Australian/US battery and electric car company Novonix, which counts former Dow Chemicals chief executive, Australian Andrew Liveris, as a director.

“We bought it at around 29c last and it is now almost $12.”

“There’s been incredible opportunities where we have made a lot of money.”

But shorting in this environment, he admits, has been difficult.

King did well shorting in the market uncertainty of the 2008 global financial crisis, but he says things are now very different.

One of the reasons has been a long period of low interest rates and easy money which means that companies with lots of debt can survive a lot longer than in the past.

“Some of the traditional red flags we have used for shorting aren’t working at the moment. Things like expensive valuations and weak balance sheets.”

King says that stocks can be given particularly high valuations when they become takeover opportunities.

With share prices so high, he says many companies are keen to use their prices for takeovers, citing the $39bn bid by US company Square for ASX listed payments company Afterpay in August in an all share deal.

With government bond yields so low, he argues that investors are now prepared to pay up more than they would have in the past for long term assets such as Sydney Airport.

He predicts that the market will continue to see more takeovers.

“The combination of low interest rates and some high share valuations mean that we are going to see a lot more corporate takeovers.”

As King knows from his own experience, shorting can have more challenges than going long.

Publicly advocating a short can lead to complaints from the company’s management who don’t like comments that their company’s share price is overvalued.

“It’s often hard to pick short ideas because management always take it personally which is always a challenge,” he says.

“But short ideas are more a reflection on valuations than anything else.”

In the US, high profile short sellers such as Wall Street fund manager, the high flying Bill Ackman, the chief executive of Pershing Square Capital, have been prepared to go public on their shorts, making speeches and presentations publicly attacking the company and outlining its shortcomings to help drive its share price down.

Ackman’s most famous play was US company Herbalife which he aggressively attacked for some five years.

But he was caught by others championing the company including Australian investor Bronte Capital’s John Hempton, finally admitting failure.

In Australia short sellers have circulated reports about companies they are shorting, with targets including financial journalists who are given an easy cheat sheets to attack a company.

The practice has attracted the attention of corporate regulator, the Australian Securities and Investments Commission (ASIC).

“Over the last five years, we have seen more of these short reports start to be issued,” King says.

“I think they are OK as long as they are fair and balanced and not personal.

“But when we start to see short reports making unsubstantiated claims we’ve got to be careful.”

King says the share market ecosystem is often biased to the long side, with analysts avoiding companies they don’t like and only issuing reports praising companies they do like.

While this is understandable, King argues that it means that there is a lack of independent research in the market about listed companies.

But King says if he reads a short report on a company he expects its writer to be shorting the stock.

“I expect someone who’s writing a short report to be short the stock, so I expect it to be biased.”

But King says it is not his practice to publicly attack a company, or privately brief journalists about a stock he is shorting, in an attempt to reduce its price.

“It’s not our style,” he says.

“We are happy to trust the market. But some people who are short like to promote their shorts to see if they can get their share price falling.”

King feels that the current share market is “a bit skittish”, as evident by its reaction to the news this week of a new Covid-19 variant, Omicron, and subsequent recovery.

He says the key thing for share markets in the current environment is not the fact that there could be a new Covid-19 virus but whether government’s lock down the economy which has a direct effect on the economy.

“It’s more the impact of the lockdown that the stock market’s worried about than the virus per se.”

King believes that there will be a good time for more shorting as in the future as the market turns.

“The best time for shorting is in bear markets, not in bull markets,” he says.

“We will have a bear market again- a true bear market, not a correction.

“Then I think there’ll be lots of opportunities for shorting.”

‍The annual Sohn conference started in New York in 1995 to commemorate the life of Ira Sohn, a Wall Street fund manager who died at the age of 29 from cancer.

‍A group of his fund manager friends decided to get together and sell tickets to a conference where they all tipped their favourite stock, to raise money for children’s cancer research.

‍The idea of the conference has spread around the world, with top fund managers tipping stocks to raise money for medical research.

‍This year’s conference in Australia, its second online as a result of Covid, will feature a video appearance by Warren Buffett’s colleague, 97 year old, Charlie Munger.

‍The Australian conferences have raised more than $30m for medical research since they started in 2016.

 

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Shorting shares has become increasingly difficult in the current long bull market, according to Regal Funds Management founder Phil King.

An experienced investor with a track record of short selling, King will be the only fund manager on the day tipping a short stock at the annual Australian Sohn Conference on Friday.

In the first Sohn Conference in 2016 he was one of three shorts pitching their ideas.

“It’s terribly tough to short shares in this bull market,” he said in an interview with the Australian ahead of the conference.

“This bull market is a much bigger bull market than many of the bull markets that we have seen. Many people who have tried to short have blown up.”

King cites the example of US video game company GameStop earlier this year.

When hedge funds decided to short the stock, retail investors, many of whom were roused to action by their presence on social media news aggregation platform Reddit, banded together and won.

But King still thinks short selling has a role in the current market.

“I’ve been shorting for 20 years. It’s more challenging now than it has been for a while, but there’s no doubt there’s going to be some great opportunities ahead.”

King will be tipping a well known Australian company for his short on Friday.

He believes that its shares are overvalued and it is in an industry which is changing, no longer as profitable as it once was.

“It’s been incredible over many years, but things have changed and now is the time to go short,” says King, who is careful not to reveal the stock itself.

“We’ve seen a lot of stocks bounce very aggressively from their lows last year.

“In some situations, they have bounced back too far. This is one of them.”

“It’s shares are overvalued. The world is changing and the future is going to be different to the past.”

In his last appearance at the Sohn conference, in 2019, King tipped ASX-listed health care equipment company PolyNovo as his short.

The company, which makes treatments for burns victims, defied his predictions, becoming a market darling in 2020 with its shares soaring to a high of $4 last December.

But investors have turned on the company this year and the company also saw the resignation of its chief executive Paul Brennan last month, with its shares crashing back to just over $1.40.

King founded Regal Funds Management in 2004 with his brother Andrew.

The two started investing for themselves but were soon approached by others to invest on their behalf.

The firm now has offices in Sydney and Singapore managing some $3bn, with a speciality in small and medium size companies.

While Andrew is retired, King says he is still enjoying himself running the business, riding the latest bull market.

“There’s been some tremendous opportunities out there. Some of the stocks are up 10 times on what we put in. It has been incredible.”

“There have been some themes which have worked well for us, like electrification.

“We have made a lot of money investing in electric vehicle stocks like (lithium miner) Pilbara (Minerals). We first bought its stock at around 35 cents and now it is trading above $2.50.”

Regal also bought Australian/US battery and electric car company Novonix, which counts former Dow Chemicals chief executive, Australian Andrew Liveris, as a director.

“We bought it at around 29c last and it is now almost $12.”

“There’s been incredible opportunities where we have made a lot of money.”

But shorting in this environment, he admits, has been difficult.

King did well shorting in the market uncertainty of the 2008 global financial crisis, but he says things are now very different.

One of the reasons has been a long period of low interest rates and easy money which means that companies with lots of debt can survive a lot longer than in the past.

“Some of the traditional red flags we have used for shorting aren’t working at the moment. Things like expensive valuations and weak balance sheets.”

King says that stocks can be given particularly high valuations when they become takeover opportunities.

With share prices so high, he says many companies are keen to use their prices for takeovers, citing the $39bn bid by US company Square for ASX listed payments company Afterpay in August in an all share deal.

With government bond yields so low, he argues that investors are now prepared to pay up more than they would have in the past for long term assets such as Sydney Airport.

He predicts that the market will continue to see more takeovers.

“The combination of low interest rates and some high share valuations mean that we are going to see a lot more corporate takeovers.”

As King knows from his own experience, shorting can have more challenges than going long.

Publicly advocating a short can lead to complaints from the company’s management who don’t like comments that their company’s share price is overvalued.

“It’s often hard to pick short ideas because management always take it personally which is always a challenge,” he says.

“But short ideas are more a reflection on valuations than anything else.”

In the US, high profile short sellers such as Wall Street fund manager, the high flying Bill Ackman, the chief executive of Pershing Square Capital, have been prepared to go public on their shorts, making speeches and presentations publicly attacking the company and outlining its shortcomings to help drive its share price down.

Ackman’s most famous play was US company Herbalife which he aggressively attacked for some five years.

But he was caught by others championing the company including Australian investor Bronte Capital’s John Hempton, finally admitting failure.

In Australia short sellers have circulated reports about companies they are shorting, with targets including financial journalists who are given an easy cheat sheets to attack a company.

The practice has attracted the attention of corporate regulator, the Australian Securities and Investments Commission (ASIC).

“Over the last five years, we have seen more of these short reports start to be issued,” King says.

“I think they are OK as long as they are fair and balanced and not personal.

“But when we start to see short reports making unsubstantiated claims we’ve got to be careful.”

King says the share market ecosystem is often biased to the long side, with analysts avoiding companies they don’t like and only issuing reports praising companies they do like.

While this is understandable, King argues that it means that there is a lack of independent research in the market about listed companies.

But King says if he reads a short report on a company he expects its writer to be shorting the stock.

“I expect someone who’s writing a short report to be short the stock, so I expect it to be biased.”

But King says it is not his practice to publicly attack a company, or privately brief journalists about a stock he is shorting, in an attempt to reduce its price.

“It’s not our style,” he says.

“We are happy to trust the market. But some people who are short like to promote their shorts to see if they can get their share price falling.”

King feels that the current share market is “a bit skittish”, as evident by its reaction to the news this week of a new Covid-19 variant, Omicron, and subsequent recovery.

He says the key thing for share markets in the current environment is not the fact that there could be a new Covid-19 virus but whether government’s lock down the economy which has a direct effect on the economy.

“It’s more the impact of the lockdown that the stock market’s worried about than the virus per se.”

King believes that there will be a good time for more shorting as in the future as the market turns.

“The best time for shorting is in bear markets, not in bull markets,” he says.

“We will have a bear market again- a true bear market, not a correction.

“Then I think there’ll be lots of opportunities for shorting.”

‍The annual Sohn conference started in New York in 1995 to commemorate the life of Ira Sohn, a Wall Street fund manager who died at the age of 29 from cancer.

‍A group of his fund manager friends decided to get together and sell tickets to a conference where they all tipped their favourite stock, to raise money for children’s cancer research.

‍The idea of the conference has spread around the world, with top fund managers tipping stocks to raise money for medical research.

‍This year’s conference in Australia, its second online as a result of Covid, will feature a video appearance by Warren Buffett’s colleague, 97 year old, Charlie Munger.

‍The Australian conferences have raised more than $30m for medical research since they started in 2016.

 

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Dec 03, 2021. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
July 4, 2023

The Artificial Intelligence Era

The semiconductor industry is entering its fourth phase - the Artificial Intelligence  era. Over roughly 50 years, the semiconductor market has gone from a nascent industry to about the size of 500bn USD today.

Read More
Over next six months, the retail sector will present some of the best buying opportunities as earnings are downgraded to more realistic levels. Over next six months, the retail sector will present some of the best buying opportunities as earnings are downgraded to more realistic levels. Over next six months, the retail sector will present some of the best buying opportunities as earnings are downgraded to more realistic levels. Over next six months, the retail sector will present some of the best buying opportunities as earnings are downgraded to more realistic levels.
July 2, 2023

The hidden gems in the Australian sharemarket

Jun Bei Liu of Tribeca Investment Partners shares her insights with The Australian Financial Review on where investors can uncover hidden gems in the Australian market for potential growth and profitability.

Read More
May 29, 2023

GSFM Conversations: Munro Partners discuss growth equities

Damien McIntyre, the CEO of GSFM, chats with Munro Partners' Portfolio Manager Kieran Moore to discuss the current investment environment and several areas of interest that have Munro's team excited.

Read More
May 26, 2023

Top stocks for today's markets (and why Jun Bei Liu believes the ASX will head higher in 2023)

Jun Bei Liu of Tribeca Investment Partners (Core and Conference Fund Manager) doesn't believe the Australian economy will nosedive into a hard landing in the next few months or years.

Read More
May 18, 2023

The key characteristics Zenith looks for when rating funds

David Wright, Co-founder of Zenith Investment Partners and member of HM1 Investment Committee recently spoke with Livewire about key characteristics Zenith looks for when rating funds.

Read More
May 17, 2023

Aggressive climate targets spell opportunity for investors

Partner and Portfolio Manager, James Tsinidis of Munro Partners (Core Fund Manager) discusses the opportunity of investing in net-zero emission companies with Firstlinks.

Read More
April 26, 2023

Stock Story: Mastercard

Read the latest Stock Story from Magellan (Core Fund Manager) about one of one of our Core Holdings, Mastercard. In the article, Magellan tap into the underlying layers that support the consistency and strength of the business.

Read More
March 18, 2023

How worried should Australians be about the US banking crisis?

Tribeca’s Alpha Plus Fund Manager, Jun Bei Liu, spoke with ABC News about the stability of the Australian financial market in the midst of the Silicone Valley Bank crisis.

Read More
March 8, 2023

How Jun Bei Liu became the $1.2 billion portfolio manager she is today

Fearlessness, resilience and plain hard work: How Jun Bei Liu became the $1.2 billion portfolio manager she is today.

Read More
February 28, 2023

Invest in the Journey: Stock Story of Liberty Media

Listen to the latest episode of Invest in the Journey, hosted by our Core Fund Manager, Munro Partners as they take a closer look at the stock story of Liberty Media – the company that owns Formula One today.

Read More
December 9, 2022

2Fold: Investing for Impact - Michael Traill AM

HM1 Director, and Director of For Purpose Investments Michael Traill AM recently joined the 2Fold: Investing for Impact Podcast where he discussed opportunities for businesses and the not-for-profit sector to work together.

Read More
August 5, 2022

Invest in the Journey: Munro's long-only strategy

Jeremy Gibson, Partner and Portfolio Manager at Munro Partners, delves into where the portfolio is currently positioned in addition to his outlook for the months and years ahead.

Read More
July 28, 2022

Munro Partners: Advanced Micro Devices

Munro Partners shares their thoughts on a company they believe has a very sustainable earnings growth trajectory ahead due to the beginning of a new era within the high performance computing sector.

Read More
July 10, 2022

Jun Bei Liu: Meet the Australian $1bn fund manager

Jun Bei Liu of Tribeca Investment Partners recalls her first encounter with the stock market as a teenager in Shanghai and how it has shaped her to become a lead portfolio manager.

Read More
April 27, 2022

Munro Partners: The Next Big S Curve

Long-time Conference Fund Manager Nick Griffin of Munro Partners with Climate Co-Portfolio Manager James Tsinidis to discuss what they think is the next big S curve.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.